Supriya Lifescience on Wednesday opened a new multipurpose active pharmaceutical ingredient (API) production block, Module E, at the Lote Parshuram site, in Maharashtra.
The facility, developed with an investment of approximately Rs 120 crore, adds a substantial capacity of 335 kiloliters to the company’s operations. This expansion boosts the Lote Parshuram capacity by over 55%, increasing it from 597 KLPD kilo liters per day) to 932 KLPD.
The new production block is designed to support Supriya’s strategic focus on expanding its R&D capabilities and scaling up its pipeline of innovative products.
The facility is tailored to support the company’s backward integration model, ensuring economies of scale and a competitive edge. It is spread across 5,000 square meters and structured over four levels, the facility enables efficient operations and safe workflows, the company said.
The facility houses 33 reactors, comprising stainless steel and glass-lined varieties, with capacities ranging from 1.6 KL to 16 KL.
Entrepreneurship
Marketing & Sales Strategies for Startups: From Concept to Conversion
By — Dr. Anu Khanchandani, Startup Coach with more than 25 years of experience
Marketing
Digital marketing — Wordpress Website Development
By — Shraddha Somani, Digital Marketing Trainer, Consultant, Strategiest and Subject Matter expert
Design
Microsoft Designer Guide: The Ultimate AI Design Tool
By — Prince Patni, Software Developer (BI, Data Science)
Finance
A2Z Of Money
By — elearnmarkets, Financial Education by StockEdge
Astrol